Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Cash from Operations (2019 - 2025)

Biodesix (BDSX) has disclosed Cash from Operations for 7 consecutive years, with 778000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 118.99% year-over-year to 778000.0, compared with a TTM value of 23271000.0 through Dec 2025, up 52.17%, and an annual FY2025 reading of 23271000.0, up 52.17% over the prior year.
  • Cash from Operations was 778000.0 for Q4 2025 at Biodesix, up from 8879000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 1090000.0 in Q2 2021 and bottomed at 18571000.0 in Q2 2024.
  • Average Cash from Operations over 5 years is 8399250.0, with a median of 9236500.0 recorded in 2022.
  • The sharpest move saw Cash from Operations soared 125.33% in 2021, then plummeted 2081.96% in 2024.
  • Year by year, Cash from Operations stood at 10197000.0 in 2021, then fell by 17.17% to 11948000.0 in 2022, then dropped by 2.8% to 12283000.0 in 2023, then soared by 66.65% to 4096000.0 in 2024, then soared by 118.99% to 778000.0 in 2025.
  • Business Quant data shows Cash from Operations for BDSX at 778000.0 in Q4 2025, 8879000.0 in Q3 2025, and 6568000.0 in Q2 2025.